The risk of adverse fetal effects differs in relation to the type of AED and for some AEDs also
the daily dose. Although for MCMs the risk is primarily associated with the first trimester of …

Women with epilepsy (WWE) wishing for a child represent a highly relevant subgroup of
epilepsy patients. The treating epileptologist needs to delineate the epilepsy syndrome and …

Objective This study was undertaken to examine the comparative safety of antiseizure
medication (ASM) monotherapy in pregnancy with respect to risk of major congenital …

Objective To assess the association between exposure to monotherapy with 10 different
antiepileptic drugs (AEDs) during the first 2 months of pregnancy and the risk of 23 major …

Background Existing data on the use of nonsteroidal anti-inflammatory drugs (NSAIDs)
during late pregnancy is well established, providing assurance. However, the use of NSAIDs …

Importance Prescription opioids are often used during pregnancy even though they are
associated with neonatal opioid withdrawal syndrome (NOWS). Most studies of adverse …

Management of seizures often involves continuous medication use throughout a patient's
life, including when a patient is pregnant. The physiological changes during pregnancy can …

Background The associations of individual antiepileptic drugs (AEDs) with pregnancy
duration and size at birth, and potential dose relations, are not well characterized. Methods …

This report is the first comprehensive update on the activities of existing epilepsy‐pregnancy
registries since 2010. The primary aim of these registries, which were initiated by …

Introduction Pregabalin is an antiepileptic drug frequently prescribed to pregnant women.
Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal …